Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-04-02 | Mr. James William BurnsChief Legal Officer | 5,22k | 0,00 | Derivative Exercise and Retained Stock | - | 49,31k | 11,84% |
| 2026-04-02 | Mr. James William BurnsChief Legal Officer | -3,28k | 113,85k | Derivative Exercise and Sale | 34,71 | 49,31k | - |
| 2026-04-02 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | -2,94k | 102,05k | Derivative Exercise and Sale | 34,71 | 80,28k | - |
| 2026-04-02 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | 5,56k | 0,00 | Derivative Exercise and Retained Stock | - | 80,28k | 7,44% |
| 2026-04-02 | Ms. Cecilia JonesCFO | -3,14k | 109,02k | Derivative Exercise and Sale | 34,71 | 55,00k | - |
| 2026-04-02 | Ms. Cecilia JonesCFO | 5,36k | 0,00 | Derivative Exercise and Retained Stock | - | 55,00k | 10,80% |
| 2026-04-02 | Ms. Tsveta MilanovaChief Commercial Officer | -3,26k | 113,22k | Derivative Exercise and Sale | 34,71 | 46,83k | - |
| 2026-04-02 | Ms. Tsveta MilanovaChief Commercial Officer | 5,24k | 0,00 | Derivative Exercise and Retained Stock | - | 46,83k | 12,59% |
| 2026-04-02 | Dr. Krishnan ViswanadhanChief Strategy & Operations Officer | -2,96k | 102,71k | Derivative Exercise and Sale | 34,71 | 10,28k | - |
| 2026-04-02 | Dr. Krishnan ViswanadhanChief Strategy & Operations Officer | 5,14k | 0,00 | Derivative Exercise and Retained Stock | - | 10,28k | 100,00% |
| 2026-04-02 | Mr. Brian M. GoffCEO & Director | -19,07k | 661,85k | Derivative Exercise and Sale | 34,71 | 184,51k | - |
| 2026-04-02 | Mr. Brian M. GoffCEO & Director | 19,96k | 0,00 | Derivative Exercise and Retained Stock | - | 184,51k | 12,13% |
| 2026-03-05 | Dr. Krishnan ViswanadhanChief Strategy & Operations Officer | 5,14k | 0,00 | Derivative Exercise and Retained Stock | - | 5,14k | - |
| 2026-03-05 | Dr. Krishnan ViswanadhanChief Strategy & Operations Officer | -2,96k | 82,26k | Derivative Exercise and Sale | 27,80 | 5,14k | - |
| 2026-03-03 | Mr. T. J. WashburnVP, Controller & Principal Accounting Officer | -5,27k | 152,26k | Verkauf | 28,88 | 868,00 | -85,86% |
| 2026-03-02 | Mr. Brian M. GoffCEO & Director | 21,45k | 0,00 | Derivative Exercise and Retained Stock | - | 164,55k | 14,99% |
| 2026-03-02 | Mr. Brian M. GoffCEO & Director | -18,06k | 522,87k | Derivative Exercise and Sale | 28,96 | 164,55k | - |
| 2026-03-02 | Mr. James William BurnsChief Legal Officer | 12,37k | 0,00 | Derivative Exercise and Retained Stock | - | 44,09k | 38,99% |
| 2026-03-02 | Mr. James William BurnsChief Legal Officer | -5,22k | 151,11k | Derivative Exercise and Sale | 28,96 | 44,09k | - |
| 2026-03-02 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | 9,61k | 0,00 | Derivative Exercise and Retained Stock | - | 74,41k | 14,83% |
| 2026-03-02 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | -4,06k | 117,43k | Derivative Exercise and Sale | 28,96 | 74,41k | - |
| 2026-03-02 | Ms. Cecilia JonesCFO | 11,93k | 0,00 | Derivative Exercise and Retained Stock | - | 49,33k | 31,91% |
| 2026-03-02 | Ms. Cecilia JonesCFO | -5,04k | 145,81k | Derivative Exercise and Sale | 28,96 | 49,33k | - |
| 2026-03-02 | Ms. Tsveta MilanovaChief Commercial Officer | 6,80k | 0,00 | Derivative Exercise and Retained Stock | - | 41,59k | 19,54% |
| 2026-03-02 | Ms. Tsveta MilanovaChief Commercial Officer | -2,87k | 83,06k | Derivative Exercise and Sale | 28,96 | 41,59k | - |
| 2026-03-02 | Mr. T. J. WashburnVP, Controller & Principal Accounting Officer | 5,27k | 0,00 | Derivative Exercise and Retained Stock | - | 6,14k | 607,37% |
| 2026-03-02 | Mr. T. J. WashburnVP, Controller & Principal Accounting Officer | -2,22k | 64,38k | Derivative Exercise and Sale | 28,96 | 6,14k | - |
| 2026-01-05 | Ms. Tsveta MilanovaChief Commercial Officer | 5,60k | 0,00 | Derivative Exercise and Retained Stock | - | 34,79k | 19,19% |
| 2026-01-05 | Ms. Tsveta MilanovaChief Commercial Officer | -2,87k | 77,60k | Derivative Exercise and Sale | 27,02 | 34,79k | - |
| 2025-12-30 | Mr. James William BurnsChief Legal Officer | 3,07k | 0,00 | Derivative Exercise and Retained Stock | - | 31,72k | 10,71% |
| 2025-12-30 | Mr. James William BurnsChief Legal Officer | -2,93k | 79,43k | Derivative Exercise and Sale | 27,09 | 31,72k | - |
| 2025-12-30 | Mr. Brian M. GoffCEO & Director | 19,58k | 0,00 | Derivative Exercise and Retained Stock | - | 143,10k | 15,85% |
| 2025-12-30 | Mr. Brian M. GoffCEO & Director | -18,70k | 506,66k | Derivative Exercise and Sale | 27,09 | 143,10k | - |
| 2025-12-30 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | 3,07k | 0,00 | Derivative Exercise and Retained Stock | - | 64,80k | 4,97% |
| 2025-12-30 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | -2,93k | 79,43k | Derivative Exercise and Sale | 27,09 | 64,80k | - |
| 2025-12-30 | Ms. Tsveta MilanovaChief Commercial Officer | 3,07k | 0,00 | Derivative Exercise and Retained Stock | - | 29,19k | 11,74% |
| 2025-12-30 | Ms. Tsveta MilanovaChief Commercial Officer | -2,93k | 79,43k | Derivative Exercise and Sale | 27,09 | 29,19k | - |
| 2025-12-30 | Ms. Cecilia JonesCFO | 3,07k | 0,00 | Derivative Exercise and Retained Stock | - | 37,39k | 8,94% |
| 2025-12-30 | Ms. Cecilia JonesCFO | -2,93k | 79,43k | Derivative Exercise and Sale | 27,09 | 37,39k | - |
| 2025-11-12 | Dr. David T. ScaddenIndependent Director | -200,00 | 5,15k | Derivative Exercise and Sale | 18,09 - 43,84 | 17,60k | - |
| 2025-11-11 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | -2,45k | 46,06k | Derivative Exercise and Sale | 25,01 - 43,78 | 61,73k | - |
| 2025-10-30 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | -200,00 | 3,76k | Derivative Exercise and Sale | 25,01 - 43,81 | 61,73k | - |
| 2025-10-27 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | -3,30k | 62,44k | Derivative Exercise and Sale | 25,01 - 43,92 | 61,73k | - |
| 2025-10-08 | Dr. David T. ScaddenIndependent Director | -200,00 | 4,58k | Derivative Exercise and Sale | 18,09 - 41,00 | 17,60k | - |
| 2025-09-30 | Dr. David T. ScaddenIndependent Director | -200,00 | 4,38k | Derivative Exercise and Sale | 18,09 - 40,00 | 17,60k | - |
| 2025-09-26 | Ms. Cecilia JonesCFO | 3,82k | 0,00 | Derivative Exercise and Retained Stock | - | 33,87k | 12,72% |
| 2025-09-26 | Ms. Cecilia JonesCFO | -3,65k | 134,25k | Derivative Exercise and Sale | 36,77 | 33,87k | - |
| 2025-09-05 | Mr. T. J. WashburnVP, Controller & Principal Accounting Officer | -8,55k | 315,09k | Verkauf | 36,87 | 868,00 | -90,78% |
| 2025-08-27 | Dr. David T. ScaddenIndependent Director | -200,00 | 4,38k | Derivative Exercise and Sale | 18,09 - 40,00 | 17,60k | - |
| 2025-08-11 | Dr. Rahul D. BallalIndependent Director | 2,30k | 0,00 | Derivative Exercise and Retained Stock | - | 12,41k | 22,77% |
| 2025-08-11 | Ms. Cynthia SmithIndependent Director | 2,30k | 0,00 | Derivative Exercise and Retained Stock | - | 12,41k | 22,77% |
| 2025-08-08 | Mr. Brian M. GoffCEO & Director | 11,61k | 0,00 | Derivative Exercise and Retained Stock | - | 123,53k | 10,37% |
| 2025-08-08 | Mr. Brian M. GoffCEO & Director | -11,09k | 406,49k | Derivative Exercise and Sale | 36,67 | 123,53k | - |
| 2025-07-10 | Dr. David T. ScaddenIndependent Director | -1,40k | 30,67k | Derivative Exercise and Sale | 18,09 - 40,00 | 17,60k | - |
| 2025-07-09 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | -11,91k | 154,63k | Derivative Exercise and Sale | 25,01 - 38,76 | 61,27k | - |
| 2025-07-01 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | 4,28k | 0,00 | Derivative Exercise and Retained Stock | - | 61,27k | 7,52% |
| 2025-07-01 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | -4,09k | 139,79k | Derivative Exercise and Sale | 34,17 | 61,27k | - |
| 2025-06-24 | Mr. James William BurnsChief Legal Officer | 3,20k | 0,00 | Derivative Exercise and Retained Stock | - | 28,65k | 12,58% |
| 2025-06-24 | Mr. James William BurnsChief Legal Officer | -2,80k | 93,88k | Derivative Exercise and Sale | 33,54 | 28,65k | - |
| 2025-06-24 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | 3,09k | 0,00 | Derivative Exercise and Retained Stock | - | 56,99k | 5,74% |
| 2025-06-24 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | -2,91k | 97,57k | Derivative Exercise and Sale | 33,54 | 56,99k | - |
| 2025-06-24 | Ms. Cecilia JonesCFO | 4,22k | 0,00 | Derivative Exercise and Retained Stock | - | 30,05k | 16,34% |
| 2025-06-24 | Ms. Cecilia JonesCFO | -1,78k | 59,70k | Derivative Exercise and Sale | 33,54 | 30,05k | - |
| 2025-06-24 | Ms. Tsveta MilanovaChief Commercial Officer | 3,23k | 0,00 | Derivative Exercise and Retained Stock | - | 26,12k | 14,11% |
| 2025-06-24 | Ms. Tsveta MilanovaChief Commercial Officer | -2,77k | 92,91k | Derivative Exercise and Sale | 33,54 | 26,12k | - |
| 2025-06-24 | Mr. Brian M. GoffCEO & Director | 19,58k | 0,00 | Derivative Exercise and Retained Stock | - | 111,92k | 21,20% |
| 2025-06-24 | Mr. Brian M. GoffCEO & Director | -18,70k | 627,20k | Derivative Exercise and Sale | 33,54 | 111,92k | - |
| 2025-06-20 | Dr. Rahul D. BallalIndependent Director | 2,12k | 0,00 | Derivative Exercise and Retained Stock | - | 10,11k | 26,53% |
| 2025-06-20 | Mr. Jeffrey D. CapelloIndependent Director | 2,12k | 0,00 | Derivative Exercise and Retained Stock | - | 6,07k | 53,63% |
| 2025-06-20 | Ms. Kaye I. Foster-CheekLead Independent Director | 2,12k | 0,00 | Derivative Exercise and Retained Stock | - | 7,47k | 39,64% |
| 2025-06-20 | Dr. Jacqualyn A. FouseChair of the Board of Directors | 2,12k | 0,00 | Derivative Exercise and Retained Stock | - | 151,34k | 1,42% |
| 2025-06-20 | Dr. Maykin HoIndependent Director | 2,12k | 0,00 | Derivative Exercise and Retained Stock | - | 17,03k | 14,22% |
| 2025-06-20 | Ms. Catherine E. Owen AdamsIndependent Director | 2,12k | 0,00 | Derivative Exercise and Retained Stock | - | 6,07k | 53,63% |
| 2025-06-20 | Dr. David T. ScaddenIndependent Director | 2,12k | 0,00 | Derivative Exercise and Retained Stock | - | 17,60k | 13,69% |
| 2025-06-20 | Ms. Cynthia SmithIndependent Director | 2,12k | 0,00 | Derivative Exercise and Retained Stock | - | 10,11k | 26,53% |
| 2025-06-13 | Mr. Jeffrey D. CapelloIndependent Director | 1,98k | 0,00 | Derivative Exercise and Retained Stock | - | 3,95k | 100,05% |
| 2025-06-13 | Ms. Catherine E. Owen AdamsIndependent Director | 1,98k | 0,00 | Derivative Exercise and Retained Stock | - | 3,95k | 100,05% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
